TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06098833: Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia

Sponsor: Pia Wintermark · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 60 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$9,544,800

Rescue Site Savings

+$6,285,600

Unlock Full NCT06098833 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06098833 Rescue Dossier →